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Abstract. Corona Virus Disease (COVID-19) is a disease caused by a new type of 
coronavirus (SARS-CoV-2). This virus was first discovered in Wuhan, China for the first 
time and has infected 90,308 people as of March 2, 2020. Infection is transmitted by large 
droplets or droplets within 1 - 2 m, which are generated during coughing and sneezing by 
symptomatic patients and people without symptoms. This infection is acquired by inhaling 
these droplets or touching a contaminated surface and then touching the nose, mouth and 
eyes.  To see the characteristics of COVID-19 patients who are treated at the Santa Elisabeth 
Hospital Medan in 2020.  Type of research is a descriptive study with a cross-sectional study 
design with a retrospective approach using total sampling technique. This type of research 
data is secondary data obtained from the medical record data of positive COVID-19 patients 
confirmed to be hospitalized in several Medan city hospitals in 2020.Of the 230 study 
samples, 147 confirmed positive COVID-19 patients were found, dominated by the age range 
46-55 years. The sex most common is male. The most common clinical symptoms are 
respiratory disorders such as coughing, shortness of breath and fever.The number of 
confirmed positive patients at the hospital. Santa Elisabeth in March to October 2020 is 147 
people (51.1%).  
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1 Introduction 
 Corona virus disease 19 (COVID-19) is a disease caused by the SARS-CoV-2 virus 
which is a new type of Coronavirus that infects the respiratory system and causes mild to severe 
symptoms. This virus was first reported in the Chinese city of Wuhan on December 31, 2019 
and has spread to two domestic cities as well as to several countries [1]. As of September 2, 
2020, COVID-19 has been found in 216 countries, with a total of 25,602,665 confirmed cases. 
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The United States is the country with the most cases of COVID-19 with a total of 5,968,380 
cases, followed by Brazil 3,908,272 cases, and India 3,769,523 cases. The first COVID-19 cases 
in Indonesia were confirmed on March 2, 2020, amounting to 2 people (Zhou et. Al, 2020. 
Meanwhile, the COVID-19 cases in Indonesia have reached 184,268 confirmed cases which 
ranks 23rd in the cumulative total of COVID-19 cases in the world at 3 September 2020 [2]. 
This study aims to determine the characteristics of confirmed COVID-19 patients based on 
clinical symptoms, age, occupation, sex, comorbids, laboratory and radiology results at the 
Santa Elisabeth Hospital in Medan starting from March to October 2020. In addition, this 
research also aims to know the results of the Polymerase Chain Reaction (PCR) swab 
examination, patient pharmacotherapy and the mortality rate for COVID-19 confirmed at the 
hospital. 
2 Method 
The research method used in this research is descriptive. The research design used by the 
author is a cross-sectional study design with a retrospective approach, namely by analyzing the 
data obtained from the patient's medical record data. The population in this study were all 
COVID-19 patients, who were treated at the hospital. Santa Elisabeth, starting from March to 
October 2020. The type of sample used was total sampling, in which the sample was determined 
by taking the entire population as research subjects. The data collected is secondary data obtained 
through the medical records of COVID-19 patients at the Santa Elisabeth Hospital, Medan. The 
data that has been obtained will be analyzed univariately and presented in the form of tables, 
diagrams or graphs. 
3.      Result 
 Research on the characteristics of COVID-19 patients has been carried out at the 
hospital. Elisabeth Medan with a total sampling method and there were 230 samples, from 
March to October 2020, 147 confirmed positive COVID-19 patients and 83 negative patients 
were found. The data were collected using the status of the patient's medical record and 
analyzed using SPSS. 
Table 1. COVID-19 patients based on PCR test 
 n  %  
Negative 83  36.1  
Positive 147  63.9  
Total  230  100  
Sumatera Medical Journal (SUMEJ) Vol. 4, No. 1, 2021  3
                                                           
 
Table 2. Characteristics of confirmed positive COVID-19 patients 
Charasteristics  n  %  
Gender Male  76  55.1  
 Female 71  48.2  
Age  0-5  1  0.7  
 6-11  0  0  
  12-16  1  0.7  
  17-25  8  5.4  
  26-35  24  16.3  
  36-45  22  15.0  
  46-55  40  27.2  
  56-65  36  24.5  
  >65  15  10.2  
Profession State-owned corporation 2  1.4  
  Housewife 20  13.6  
  Private employees  41  27.9  
  College student 8  5.4  
  Student  1  0.7  
  Retired  17  11.6  
  Farmer  2  1.4  
  Civil Servant  19  12.9  
  Medical personnel 6  4.1  
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Table 3 Symptoms and clinical criteria 
   n                     %  
Respiratory Cough  144  98.0  
 Dispnea  137  93.2  
 Anosmia  1  0.7  
Non Respiratori  fever  129  87.8  
 Vomitus  65  44.2  
 Nausea  21  14.3  
 Fatigue  97  66.0  
 Disfagia 40  27.2  
 Malaise  74  50.3  
Kriteria Klinis  Very Severe  16  10.9  
 Severe  5  3.4  
 Mild  5  3.4  
 Moderatte  121  82.3  
 
Table 4 Comorbid 








            TBC  
            Bronchitis 









Kidney Disease 3  2.0  
Heart Disease 29  17.7  
Liver Disease  5  3.4  
Dyspepsia Syndrom  37  25.2  
Diabetes Melitus  27  18.4  
Cancer  3  2.0  
Autoimun  3                  2.0  
 
 
Sumatera Medical Journal (SUMEJ) Vol. 4, No. 1, 2021  5
                                                           
Table 5 Laboratory Examination 
  Normal Increase  Decrease  















Hb  101  68,7  9  6,1  37  25,3  
Platelet  114  77,6  20  13,6  13  8,8  
Leukocytes 93  63,3  37  25,2  17  11,6  
Lymphocytes 61  41,5  61  41,5  77  52,4  
ALC  64  43,5      69  46,9  
Eosinophils 120  81,6  27  18,6      
CRP  46  31,1  101  68,7      
Troponin  84  57,1  38  25,9      
Prokalsitonin  82  55,8  51  34,7      
D-dimer  54  39.1  84  60,8      
 
Table 6. Blood and sputum culture examination of patients COVID-19 positive 
confirmation 
Culture Type   n % 
Blood Exist Micrococcus lentus 2  
  Salmonella thypi 2  
  Staphylococcus epidermidis 1  
  Staphylococcus hominis 1  
  Staphylococcus saprophyticus 1  
  Staphylococcus lentus 1  
Sputum  Pseudomonas aeruginosa 1  
  Acinetobacter lwoffi 1  
  Staphylococcus hominis 2  
  Pseudomonas stutzeri 1  
  Pseudomonas aeruginosa 1  
  Yeast cell 1  






Sumatera Medical Journal (SUMEJ) Vol. 4, No. 1, 2021  6
                                                           
Tabel 7. Radiological examination of chest X-ray and CT scan of the patient COVID-19 
positive confirmation 
   n % 
Chest X-ray Normal  29 19.7 
 Abnormal  118 80.3 
  Bilateral 
bronchopneumonia 
109  
  Fibrosis 7  
  Bilateral bronchiectasis 2  
  Cardiomegaly 7  
  Pleural Effusion 1  
  Calcification 1  
  Infiltrat 1  









 Abnormal  23 76.6 
  GGO 12  
  Consilodation 3  
  Fibrosis 3  
  Bilateral 
bronchopneumonia 
2  
 Total  30       100 
 
Table 8. Pharmacological therapies such as antivirals, antibiotics, and other drugs 
  n % 
Antiviral Hidroxychroloquine 135 91.8 
 Ritonavir 125 85.0 
 Oseltamivir 138 93,9 
 Klorokuin 21 14.3 
Antibiotik Levofloxacin 69 46.9 
 Azithromycin 139 94.6 
 Meropenem 128 87.1 
 Vancomycin 91 61.9 
 Fosfomycin 32 21.8 
Linezolid 9 6.1 
 Cefoperazone 15 10.2 
Other Drugs NAC 139 94.5 
 Vit C 147 100 
 Proove D3 147 100 
 Curcuma 128 87.0 
 Zink 147 100 
 Terapi Simtomatik 147 100 
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Table 9. The case fatality rate of COVID-19 patients was confirmed positive from 
March to October 
 n % 
Life 142 96.5 
Death 5 3.4 
Total 147 100 
 
Table 1 illustrates that there are 230 research samples, and based on PCR examination, 147 
samples (63.9%) were positive and 83 samples (36.1%) were negative. 
Table 2 illustrates that of the 147 samples, there were 76 (55.1%) male samples and 71 female 
samples. The age group most diagnosed with confirmed positive COVID-19 was 46-55 years, 
namely 40 samples (27.2%). types of work that contracted the most COVID-19 were private 
employees, namely 41 (27.9%) and private employees as many as 31 samples (21.1%). 
Table 3 illustrates that the most common clinical symptoms are cough clinical symptoms found 
in 144 samples (98.0%), spasms in 137 samples (93.2%), fever in 129 samples (87.8%). 
Table 4 illustrates that there are 121 samples (82.3%) which are moderate clinical criteria, then 
followed by severe clinical criteria, namely 16 samples (10.9%), critical with 5 samples (3.4%) 
and mild with 5 samples (3, 4%). 
Table 4 illustrates that the comorbid dyspepsia syndrome was found in 37 samples (22.5%). Heart 
disease in the form of heart failure, coronary heart disease and myocardial infarction, there were 
29 samples (17.7%). There were 27 samples of type 2 diabetes mellitus (18.4%). hypertension 
was found in 27 samples (18.4%). 
Table 5 illustrates that on routine blood tests found an increase in the value of leukocytes in 37 
(25.2%) samples. Lymphocyte values were found to be increased in 61 samples (41.5%) and 
decreased ALC values were found in 69 samples (46.9%). CRP values were found to be increased 
in 101 samples (68.7%). Troponin values were found to be increased in 38 samples (25.9%). 
Procalcitonin values were found to be elevated in 51 samples (34.7%). The increase in the D-
dimer value was found to be more, namely from 138 samples there was an increase in 84 samples 
(60.8%) and this result indicates a state of hypercoagulability. 
Table 6 describes the examination of bacterial cultures carried out on 147 samples and found 100 
samples (68%) with the results of the examination that there was no bacterial growth and there 
were bacteria in 15 samples (10.2%). 
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Table 7 describes the results of chest X-ray examinations performed on 147 samples, of which 
188 samples (80.3%) had abnormal thoracic images with the most pictures, bilateral 
bronchopneumoni. And on the CT scan, there is an abnormal picture in the form of consolidation, 
multiple groundglass shadows, fibrosis, and cardiomegaly. 
Table 8 describes the use of the antiviral type hydroxychroloquine (HCQ) found in 135 samples 
(91.8%). The use of antiviral lopivia was found in 125 samples (85.0%). The type of antiviral 
most often used was chloroquine with 21 samples (14.3%). And oseltamivir was the most widely 
used antiviral, with 138 samples (93.9%). The most widely used type of antibiotic was 
azithromycin with 139 samples (94.6%). Then meropenem with 128 samples (87.1%), 
levofloxacin as many as 69 samples (46.9%), Fosfomycin as many as 32 samples (21.8%), 
cefoperazone as many as 15 samples (10.2%). For other drugs it can be seen that Vitamin C, 
Proove D3 and Zink were used in 147 samples (100%), while N-acetylcstein was 
4. Discussion 
In this study, it was found that more confirmed cases were found than negative cases. 
Several factors can increase the risk of COVID-19, such as the elderly (> 60 years), toddlers, 
pregnant women, people with disabilities, and / or comorbidities such as: heart disease, diabetes 
/ diabetes, lung disease, cancer, high blood pressure, stroke, [3]. Male sex is also more exposed 
to COVID-19 in men, which is thought to be associated with a higher prevalence of active 
smoking. In smokers, hypertension, and diabetes mellitus, it is suspected that there is an increase 
in ACE2 receptor expression [4,5]. Most cases of COVID-19 occurred in the age range 45-54 
years and at least occurred at the age of 0-5 years [2]. Types of work that increase the risk of 
contracting COVID-19 are jobs that often involve the general public, visitors, or customers in a 
crowded work environment (such as food markets, bus terminals, public transportation, and other 
work activities where physical distancing is minimal. 1 meter is difficult to adhere to), or work 
tasks that require frequent close contact with coworkers [6]. In COVID-19, the most common 
clinical symptoms are respiratory clinical symptoms, because in humans, SARS-CoV-2 primarily 
infects cells in the airways that line the alveoli, SARS-CoV-2 binds to receptors and creates a 
pathway. enter the cell [7]. On blood tests, the leukocyte count can be found to be normal or 
decreased, the lymphocyte count decreases and the increase in inflammatory markers such as CRP 
and procalcitonin. And in some samples who experienced heart problems such as CHF, CHD, 
myocardial infarction, an increase in troponin values was found [7,8].  
Chest X-ray can reveal features such as ground-glass opacification, infiltrates, focal 
consolidation, pleural effusion, and atelectasis while CT-scan can reveal bilateral opacities, 
subsegmental consolidation, lobar or pulmonary collapse or nodules, groundglass view [10]. 
Pharmacological therapies recommended in COVID-19 patients are oseltamivir, lopinavir, 
Hidroxychroloquine, rendemsivir, chloroquine, fapivavir and ritonavir which are recommended 
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antivirals for COVID-19 therapy [11]. The use of Vitamin C as management in COVID-19 is 
very important, where the provision of vitamin C can accelerate the improvement in cases of 
COVID-19 which works on plasma and neutrophils, besides that Vitamin C can also ward off free 
radicals and prevent oxidative stress by coronavirus and it is also proven, in the journal that with 
the administration of high doses of vitamin C, there is a rapid improvement of the radiological 
chest X-ray image after several days of therapy [12]. 
5. Conclusion 
Based on the results of the research from the data obtained, the conclusions obtained were 
that in 2020 there were 230 patients with positive COVID-19 status confirmation based on RT-
PCR examinations totaling 147 patients. The most common age range for confirmed positive 
COVID-19 patients is 40-45 years. The most common sex with confirmed positive COVID-19 is 
male. The types of work that contracted the most COVID-19 are private employees. The most 
common clinical symptoms are respiratory symptoms, such as coughing and tightness. On blood 
tests found an increase in leukocytes, CRP, procalcitonin, D-dimer, and a decrease in lymphocyte 
and ALC values and Case fatality rate (CFR) in patients with positive COVID-19 confirmation at 
the hospital. Santa Elisabeth Medan from March to October 2020 amounting to 3.4% 
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